13-51937502-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_000053.4(ATP7B):c.3877G>A(p.Glu1293Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1293D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP7B | NM_000053.4 | c.3877G>A | p.Glu1293Lys | missense_variant | Exon 18 of 21 | ENST00000242839.10 | NP_000044.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP7B | ENST00000242839.10 | c.3877G>A | p.Glu1293Lys | missense_variant | Exon 18 of 21 | 1 | NM_000053.4 | ENSP00000242839.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 249510 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461742Hom.: 0 Cov.: 35 AF XY: 0.00000688 AC XY: 5AN XY: 727154 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Wilson disease Pathogenic:4Uncertain:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1293 of the ATP7B protein (p.Glu1293Lys). This variant is present in population databases (rs776300396, gnomAD 0.02%). This missense change has been observed in individual(s) with Wilson disease (PMID: 22484412, 22745856, 25982861, 31172689, 34470610, 35220961; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 553585). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ATP7B protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Variant summary: ATP7B c.3877G>A (p.Glu1293Lys) results in a conservative amino acid change located in the P-type ATPase, haloacid dehalogenase domain (IPR044492) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 249510 control chromosomes (i.e., 5 heterozygotes; gnomAD v2.1, Exomes dataset). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3877G>A has been reported in the literature in individuals affected with Wilson Disease (e.g., Cho_2011, Dong_2016, Guggilla_2015, Lepori_2012, Li_2019, Li_2021, Zhang_2022). These data indicate that the variant is likely be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22745856, 27022412, 25982861, 22484412, 34470610, 31172689, 35220961). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (likely pathogenic, n = 2; VUS, n = 2; pathogenic, n = 1). Based on the evidence outlined above, the variant was classified as likely pathogenic.
This missense variant replaces glutamic acid with lysine at codon 1293 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been observed in individuals affected with autosomal recessive Wilson disease (PMID: 22745856, 25982861, 27022412, 34470610). This variant has been identified in 6/280894 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
not provided Pathogenic:2
PP3, PP4, PM2, PM3, PS4_moderate
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at